Conference Reporter

Systemic Lupus Erythematosus

Update on Systemic Lupus Erythematosus Biomarkers and Prognostication

conference reporter
By Vasileios C. Kyttaris, MD

Plaque Psoriasis

Real-World Experience With IL-17 and IL-23 Inhibitors for Plaque Psoriasis

conference reporter
By Boni E. Elewski, MD

Gastroenteropancreatic Neuroendocrine Tumors

Personalizing Therapy for Patients With Gastroenteropancreatic Neuroendocrine Tumors

conference reporter
By Thorvadur R. Halfdanarson, MD

IgAN & C3G

Challenges in Managing Complement 3 Glomerulopathy

conference reporter
By Andrew S. Bomback, MD, MPH

Paroxysmal Nocturnal Hemoglobinuria

Conference Reporter in Paroxysmal Nocturnal Hemoglobinuria to Cover Key Topics Being Presented at the 65th ASH Annual Meeting and Exposition

conference reporter
By Ronald S. Go, MD; Jaroslaw P. Maciejewski, MD, PhD, FACP

Gastroenteropancreatic Neuroendocrine Tumors

Gastroenteropancreatic Neuroendocrine Tumors: Clinical Trials and Future Directions

conference reporter
By Thorvadur R. Halfdanarson, MD

IgAN & C3G

The Evolving Treatment Landscape for Immunoglobulin A Nephropathy

conference reporter
By Andrew S. Bomback, MD, MPH

Plaque Psoriasis

Psoriasis in Patients With Skin of Color: Diagnosis and Management Considerations

conference reporter
By Boni E. Elewski, MD

Gastroenteropancreatic Neuroendocrine Tumors

Interdisciplinary Perspectives on Grade Evolution in Gastroenteropancreatic Neuroendocrine Tumors

conference reporter
By Jennifer R. Eads, MD

IgAN & C3G

Exploring the Therapeutic Landscape for Complement-Mediated Kidney Diseases

conference reporter
By Andrew S. Bomback, MD, MPH

Plaque Psoriasis

Choosing Systemic Agents for Psoriasis: What Clinicians Need to Know Now

conference reporter
By Boni E. Elewski, MD

Systemic Lupus Erythematosus

Autoimmunity and Autoantibody Profiles in Systemic Lupus Erythematosus

conference reporter
By Vasileios C. Kyttaris, MD

RheumatologySystemic Lupus Erythematosus

Advancements in Systemic Lupus Erythematosus: Entering a New Era

conference reporter
By Maureen A. McMahon, MD

Gastroenteropancreatic Neuroendocrine Tumors

Conference Reporter in GEP-NETs to Cover Key Topics Being Presented at the 2023 NANETS Multidisciplinary NET Medical Symposium

conference reporter
By Jennifer R. Eads, MD; Thorvadur R. Halfdanarson, MD

Plaque Psoriasis

Conference Reporter in Plaque Psoriasis to Cover Key Topics Being Presented at the 2023 Fall Clinical Dermatology Conference

conference reporter
By Boni E. Elewski, MD; Bruce E. Strober, MD, PhD

Metastatic Prostate Cancer

Transitioning From a Conventional Imaging Paradigm to a Next-Generation Imaging Paradigm

conference reporter
By Tom Iarocci, MD

Metastatic Prostate Cancer

Conference Reporter and Highlight Article: Important Aspects of Care in Advanced Prostate Cancer

conference commentary
By Tanya B. Dorff, MD; Tom Iarocci, MD

Metastatic Prostate Cancer

Conference Reporter and Highlight Article: Spotlight on Prostate-Specific Membrane Antigen–Targeted Radioligand Therapy

conference commentary
By Scott T. Tagawa, MD, MS, FACP; Tom Iarocci, MD

Metastatic Prostate Cancer

Patient Selection and Treatment Personalization With Prostate-Specific Membrane Antigen–Directed Radioligand Therapy

conference reporter
By Tom Iarocci, MD

HR+ HER2- Breast Cancer

Thinking Differently About Breast Cancer in Young Women

conference reporter
By Ian Krop, MD, PhD

HR+ HER2- Breast Cancer

CDK4/6 Inhibition and Endocrine Resistance in Advanced HR+ HER2- Breast Cancer

conference reporter
By Ian Krop, MD, PhD

Metastatic Prostate Cancer

Updates on Prostate-Specific Membrane Antigen Positron Emission Tomography

conference reporter
By Tom Iarocci, MD

HR+ HER2- Breast Cancer

Selective Estrogen Receptor Degraders and Other Novel Agents in Breast Cancer: Where Do We Stand?

conference reporter
By Sara M. Tolaney, MD, MPH

Chronic Myeloid Leukemia

Chronic Myeloid Leukemia at EHA2023: Conference Roundup

conference reporter
By Daniel J. DeAngelo, MD, PhD

HR+ HER2- Breast Cancer

CDK4/6 Inhibition in Advanced HR+ HER2- Breast Cancer

conference reporter
By Sara M. Tolaney, MD, MPH

Chronic Myeloid Leukemia

Treatment-Free Remission in Chronic Myeloid Leukemia: How to Optimize Eligibility and Improve Success Rates

conference reporter
By Elias Jabbour, MD

Metastatic Prostate Cancer

Gaining Experience With Prostate-Specific Membrane Antigen–Directed Radioligand Therapy

conference reporter
By Tom Iarocci, MD

Metastatic Prostate Cancer

Conference Reporter in Metastatic Prostate Cancer to Cover Key Topics Being Presented at SNMMI 2023

conference reporter
By Tom Iarocci, MD

Chronic Myeloid Leukemia

Late-line Treatment in Chronic-Phase Chronic Myeloid Leukemia

conference reporter
By Elias Jabbour, MD

Systemic Lupus Erythematosus

Systemic Lupus Erythematosus Roundup at Eastern Rheumatology Congress

conference reporter
By Maureen A. McMahon, MD

Systemic Lupus Erythematosus

Addressing Refractory Systemic Lupus Erythematosus

conference reporter
By Anca D. Askanase, MD, MPH

IgAN & C3G

Glomerular Disease: Conference Roundup on Immunoglobulin A Nephropathy, Complement 3 Glomerulopathy, and Focal Segmental Glomerulosclerosis

conference reporter
By Samir V. Parikh, MD, FASN

HR+ HER2- Breast Cancer

Conference Reporter in HR+ HER2- Breast Cancer to Cover Key Topics Being Presented at the 2023 ASCO Annual Meeting

conference reporter
By Ian Krop, MD, PhD; Sara M. Tolaney, MD, MPH

IgAN & C3G

New Studies and Emerging Data on Complement-Driven Kidney Diseases

conference reporter
By Samir V. Parikh, MD, FASN

Systemic Lupus Erythematosus

Systemic Lupus Erythematosus: Response to Treatment With Newer Therapies

conference reporter
By Vasileios C. Kyttaris, MD

IgAN & C3G

Case for Consideration: Glomerular Diseases at a National Kidney Disease Conference

conference reporter
By Carla M. Nester, MD, MSA, FASN

Chronic Myeloid Leukemia

Conference Reporter in Chronic Myeloid Leukemia to Cover Key Topics Being Presented at EHA2023 Hybrid Congress

conference reporter
By Daniel J. DeAngelo, MD, PhD; Elias Jabbour, MD

IgAN & C3G

Unmet Needs and Targeted Treatments for Glomerular Diseases

conference reporter
By Carla M. Nester, MD, MSA, FASN

IgAN & C3G

Improving Outcomes in Complement-Mediated Kidney Disease

conference reporter
By Andrew S. Bomback, MD, MPH

IgAN & C3G

Immunoglobulin A Nephropathy: Challenges and Emerging Treatments

conference reporter
By Andrew S. Bomback, MD, MPH

Systemic Lupus Erythematosus

Conference Reporter in Systemic Lupus Erythematosus to Cover Key Topics Being Presented at CCR East, CCR West, and ACR Convergence 2023

conference reporter
By Anca D. Askanase, MD, MPH; Maureen A. McMahon, MD; Vasileios C. Kyttaris, MD

IgAN & C3G

Conference Reporter in IgAN and C3G – Complement Mediated Kidney Diseases to Cover Key Topics Being Presented at the NKF 2023 Spring Clinical Meetings

conference reporter
By Andrew S. Bomback, MD, MPH; Carla M. Nester, MD, MSA, FASN; Samir V. Parikh, MD, FASN

Chronic Myeloid Leukemia

Treatment-Free Remission in Chronic Myeloid Leukemia

conference reporter
By Michael J. Mauro, MD

Chronic Myeloid Leukemia

Chronic Myeloid Leukemia: Unmet Needs and Trials in Progress

conference reporter
By Michael J. Mauro, MD

Paroxysmal Nocturnal Hemoglobinuria

Next-Generation Complement Inhibitors for Paroxysmal Nocturnal Hemoglobinuria

conference reporter
By Jaroslaw P. Maciejewski, MD, PhD, FACP

Paroxysmal Nocturnal Hemoglobinuria

Flow Cytometry and Clonal Considerations in Paroxysmal Nocturnal Hemoglobinuria

conference reporter
By Jaroslaw P. Maciejewski, MD, PhD, FACP

Chronic Myeloid Leukemia

Later-line Treatments in Chronic Myeloid Leukemia

conference reporter
By Neil P. Shah, MD, PhD

Paroxysmal Nocturnal Hemoglobinuria

Future Directions for Paroxysmal Nocturnal Hemoglobinuria Treatment

conference reporter
By Carlos M. de Castro III, MD

Paroxysmal Nocturnal Hemoglobinuria

Extravascular Hemolysis and Residual Anemia in Paroxysmal Nocturnal Hemoglobinuria

conference reporter
By Carlos M. de Castro III, MD

Chronic Myeloid Leukemia

Tolerability of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia

conference reporter
By Neil P. Shah, MD, PhD

Chronic Myeloid Leukemia

Evolving Practices in the Treatment of Chronic Myeloid Leukemia

conference reporter
By Hagop M. Kantarjian, MD

Paroxysmal Nocturnal Hemoglobinuria

Complications and Comorbidities in Paroxysmal Nocturnal Hemoglobinuria

conference reporter
By Ronald S. Go, MD

Paroxysmal Nocturnal Hemoglobinuria

Paroxysmal Nocturnal Hemoglobinuria: Initial Presentation, Diagnosis, and Management

conference reporter
By Ronald S. Go, MD

Chronic Myeloid Leukemia

BCR::ABL1 Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia: The Current Landscape

conference reporter
By Hagop M. Kantarjian, MD

Paroxysmal Nocturnal Hemoglobinuria

Conference Reporter in Paroxysmal Nocturnal Hemoglobinuria to Cover Key Topics Being Presented at the 64th ASH Annual Meeting and Exposition

conference reporter
By Carlos M. de Castro III, MD; Jaroslaw P. Maciejewski, MD, PhD, FACP; Ronald S. Go, MD

Geographic Atrophy

Novel Disease Biomarkers and Artificial Intelligence in Age-Related Macular Degeneration and Geographic Atrophy

conference reporter
By SriniVas R. Sadda, MD, FARVO

Geographic Atrophy

Optical Coherence Tomography and Multimodal Diagnostics in Age-Related Macular Degeneration and Geographic Atrophy

conference reporter
By SriniVas R. Sadda, MD, FARVO

Geographic Atrophy

Geographic Atrophy in Age-Related Macular Degeneration: Novel Strategies Targeting the Complement System

conference reporter
By Carl D. Regillo, MD, FACS, FASRS

Geographic Atrophy

The Natural History of Age-Related Macular Degeneration and Geographic Atrophy

conference reporter
By Carl D. Regillo, MD, FACS, FASRS

Geographic Atrophy

Potential of Gene Therapy for Age-Related Macular Degeneration

conference reporter
By Peter K. Kaiser, MD

Geographic Atrophy

Future Management of Geographic Atrophy in Age-Related Macular Degeneration

conference reporter
By Peter K. Kaiser, MD

Geographic Atrophy

Conference Reporter in Geographic Atrophy to Cover Key Topics Being Presented at the 2022 Annual Meeting of the American Academy of Ophthalmology

conference reporter
By Carl D. Regillo, MD, FACS, FASRS; Peter K. Kaiser, MD; SriniVas R. Sadda, MD, FARVO

Immuno-Oncology

Earlier-Stage Non–Small Cell Lung Cancer: Immunotherapy Highlights

conference reporter
By Bruce E. Johnson, MD

Immuno-Oncology

Advanced Solid Tumors: New Directions for Checkpoint Blockade

conference reporter
By Bruce E. Johnson, MD

Immuno-Oncology

Biomarkers of Response to PD-1/PD-L1–Directed Therapy

conference reporter
By Mark G. Kris, MD

Immuno-Oncology

Appreciating the Complexity: Immune Escape and Immune-Related Side Effects

conference reporter
By Mark G. Kris, MD

Immuno-Oncology

Precision Immunotherapy and Novel Concepts in Immuno-Oncology

conference reporter
By Julie R. Brahmer, MD, MSc

Immuno-Oncology

Established and Emerging Immune Checkpoint Inhibitor Combination Strategies

conference reporter
By Julie R. Brahmer, MD, MSc

Immuno-Oncology

Conference Reporter in Immuno-Oncology to Cover Key Topics Being Presented at the 2022 ASCO Annual Meeting

conference reporter
By Bruce E. Johnson, MD; Julie R. Brahmer, MD, MSc; Mark G. Kris, MD

Metastatic Prostate Cancer

First-in-Class Prospects and New Targets in Advanced Prostate Cancer

conference reporter
By Christopher J. Logothetis, MD

Metastatic Prostate Cancer

Treatment Decision Making: Understanding What Matters to Patients With Metastatic Castration-Resistant Prostate Cancer

conference reporter
By Christopher J. Logothetis, MD

Metastatic Prostate Cancer

Predictive and Prognostic Value of Advanced Positron Emission Tomography Imaging

conference reporter
By Scott T. Tagawa, MD, MS, FACP

Metastatic Prostate Cancer

Implementing Novel Targeted Radioligand Therapies

conference reporter
By Scott T. Tagawa, MD, MS, FACP

Metastatic Prostate Cancer

Disparities in Prostate Cancer Care

conference reporter
By Judd W. Moul, MD

Metastatic Prostate Cancer

Biomarker Testing in the Emerging Treatment Era

conference reporter
By Judd W. Moul, MD

Chronic Lymphocytic Leukemia

Chronic Lymphocytic Leukemia: Real-World Data on Testing and Treatment

conference reporter
By Anthony R. Mato, MD, MSCE

Chronic Lymphocytic Leukemia

Investigational Novel-Novel Combinations for Chronic Lymphocytic Leukemia

conference reporter
By Anthony R. Mato, MD, MSCE

Chronic Myeloid Leukemia

COVID-19 in Chronic Myeloid Leukemia and Other Hematologic Malignancies

conference reporter
By Jorge E. Cortes, MD

Chronic Myeloid Leukemia

Molecular Status for the Discontinuation of Tyrosine Kinase Inhibitor Therapy

conference reporter
By Jorge E. Cortes, MD

Chronic Myeloid Leukemia

Resistance and Persistence in Chronic Myeloid Leukemia

conference reporter
By Elias Jabbour, MD

Chronic Myeloid Leukemia

Unmet Needs in Chronic Myeloid Leukemia and Insights From Next-Generation Studies

conference reporter
By Elias Jabbour, MD

Chronic Lymphocytic Leukemia

Taking a Whole-Patient Approach to Treating Chronic Lymphocytic Leukemia

conference reporter
By Matthew S. Davids, MD, MMSc

Chronic Lymphocytic Leukemia

Extending Progression-Free and Overall Survival in Chronic Lymphocytic Leukemia

conference reporter
By Matthew S. Davids, MD, MMSc

Chronic Lymphocytic Leukemia

Chronic Lymphocytic Leukemia Treatment Patterns in the Era of Novel Agents

conference reporter
By Jan A. Burger, MD, PhD

Chronic Myeloid Leukemia

Tyrosine Kinase Inhibitor Therapy for Chronic Myeloid Leukemia: Real-World Data

conference reporter
By Daniel J. DeAngelo, MD, PhD

Chronic Myeloid Leukemia

Important Frontiers in Chronic Myeloid Leukemia Research

conference reporter
By Daniel J. DeAngelo, MD, PhD

Chronic Lymphocytic Leukemia

Long-term Survival Data With Preferred Frontline Therapies for Chronic Lymphocytic Leukemia

conference reporter
By Jan A. Burger, MD, PhD

Liver Fibrosis

Noninvasive Testing for Fatty Liver Disease and Its Different Phenotypes

conference reporter
By Kris V. Kowdley, MD, FACP, FACG, AGAF, FAASLD

Liver Fibrosis

Multidisciplinary Care for Nonalcoholic Fatty Liver Disease

conference reporter
By Kris V. Kowdley, MD, FACP, FACG, AGAF, FAASLD

Liver Fibrosis

The Gut-Liver Axis and the Microbiome in Liver Inflammation and Fibrosis

conference reporter
By Ashwani K. Singal, MD, MS, AGAF, FACG, FAASLD

Liver Fibrosis

Novel Approaches to Detect Liver Disease

conference reporter
By Ashwani K. Singal, MD, MS, AGAF, FACG, FAASLD

Liver Fibrosis

Therapies on the Horizon for Nonalcoholic Steatohepatitis

conference reporter
By Rohit Loomba, MD, MHSc

Chronic Lymphocytic Leukemia

Conference Reporter in Chronic Lymphocytic Leukemia to Cover Key Topics Being Presented at the 63rd ASH Annual Meeting and Exposition

conference reporter
By Anthony R. Mato, MD, MSCE; Jan A. Burger, MD, PhD; Matthew S. Davids, MD, MMSc

Liver Fibrosis

Noninvasive Tests to Risk Stratify Patients With Fatty Liver Disease

conference reporter
By Rohit Loomba, MD, MHSc

Liver Fibrosis

Conference Reporter in Liver Fibrosis to Cover Key Topics Being Presented at Recent Liver Disease Meeting

conference reporter
By Ashwani K. Singal, MD, MS, AGAF, FACG, FAASLD; Kris V. Kowdley, MD, FACP, FACG, AGAF, FAASLD; Rohit Loomba, MD, MHSc

Metastatic Prostate Cancer

Imaging-Based Patient Selection for Advanced Prostate Cancer Therapies

conference reporter
By Michael S. Cookson, MD, MMHC, FACS

Metastatic Prostate Cancer

Practice-Changing Radiology and Nuclear Medicine in Advanced Prostate Cancer

conference reporter
By Michael S. Cookson, MD, MMHC, FACS

Metastatic Prostate Cancer

Advanced Prostate Cancer: Novel Approaches for Distant Disease

conference reporter
By Robert Dreicer, MD, MS, MACP, FASCO

Metastatic Prostate Cancer

Biomarker-Driven Targeted Treatments in Metastatic Castration-Resistant Prostate Cancer

conference reporter
By Robert Dreicer, MD, MS, MACP, FASCO

Advanced Hormone-Sensitive Prostate Cancer

High-Risk Locally Advanced Prostate Cancer: Session Roundup

conference reporter
By Daniel P. Petrylak, MD

Advanced Hormone-Sensitive Prostate Cancer

Metastatic Hormone-Sensitive Prostate Cancer: Analyses and Emerging Data

conference reporter
By Daniel P. Petrylak, MD

Metastatic Prostate Cancer

Genomic Testing and Predictive Biomarkers in Advanced Prostate Cancer

conference reporter
By William K. Oh, MD

Metastatic Prostate Cancer

Clinical Trial Announcements and Studies to Follow

conference reporter
By William K. Oh, MD

Advanced Hormone-Sensitive Prostate Cancer

Gonadotropin-Releasing Hormone Agonists and Antagonists: Updates and Considerations

conference reporter
By Peter R. Carroll, MD, MPH

Advanced Hormone-Sensitive Prostate Cancer

Controversies in Urology: Prostate Biopsy Best Practices

conference reporter
By Peter R. Carroll, MD, MPH

Advanced Hormone-Sensitive Prostate Cancer

The Future of Urologic Oncology: Treatment Advances Spur Discussion

conference reporter
By Joseph A. Smith Jr, MD

Advanced Hormone-Sensitive Prostate Cancer

Guidelines From the Advanced Prostate Cancer Panel

conference reporter
By Joseph A. Smith Jr, MD

Advanced Hormone-Sensitive Prostate Cancer

Conference Reporter in Advanced Hormone-Sensitive Prostate Cancer to Cover Key Topics Being Presented at AUA2021

conference reporter
By Daniel P. Petrylak, MD; Joseph A. Smith Jr, MD; Peter R. Carroll, MD, MPH

Metastatic Prostate Cancer

Promise in Treatment Personalization for Advanced Prostate Cancer

conference reporter
By E. David Crawford, MD

Metastatic Prostate Cancer

Metastatic Prostate Cancer: Predictive Biomarkers for Tailored Therapy

conference reporter
By E. David Crawford, MD

Metastatic Prostate Cancer

Novel and Emerging Treatments for Progressive Metastatic Castration-Resistant Prostate Cancer

conference reporter
By William K. Oh, MD

Metastatic Prostate Cancer

Treatment Sequence in Patients With Castration-Resistant Prostate Cancer

conference reporter
By William K. Oh, MD

Metastatic Prostate Cancer

High-Risk and Locally Advanced Prostate Cancer: Clinical Roundup

conference reporter
By Peter R. Carroll, MD, MPH

Metastatic Prostate Cancer

Prostate-Specific Membrane Antigen–Targeted Therapies: Expert Insights

conference reporter
By Peter R. Carroll, MD, MPH

Epilepsy

Real-World Care of Patients With Epilepsy

conference reporter
By Sara Hocker, MD, FAAN

Epilepsy

Drug-Resistant Epilepsy and Related Clinical Trials and Registries

conference reporter
By Sara Hocker, MD, FAAN

Aggressive B-Cell Lymphoma

Aggressive B-Cell Non-Hodgkin Lymphoma: Molecular Profiling and Post-Treatment Surveillance

conference reporter
By David Miklos, MD, PhD

Multiple Myeloma

Expanding Horizons: Antibody-Based Therapy in Multiple Myeloma

conference reporter
By Paul G. Richardson, MD

Multiple Myeloma

Novel and Emerging Therapeutic Strategies for Multiple Myeloma

conference reporter
By Paul G. Richardson, MD

Epilepsy

Newer and Emerging Therapies for Uncontrolled Focal Seizures

conference reporter
By John M. Stern, MD

Aggressive B-Cell Lymphoma

Optimizing CAR T-Cell Therapy and Durability of Response in Aggressive B-Cell Lymphoma

conference reporter
By Frederick L. Locke, MD

Epilepsy

Epileptic Syndromes and the Future of Epilepsy Genetics

conference reporter
By John M. Stern, MD

Aggressive B-Cell Lymphoma

Cellular and Immune-Based Therapies for Relapsed Aggressive B-Cell Lymphoma

conference reporter
By Frederick L. Locke, MD

Multiple Myeloma

Research to Address Unmet Needs in Multiple Myeloma

conference reporter
By S. Vincent Rajkumar, MD

Epilepsy

Psychiatric Comorbidity and the Evaluation of Epilepsy

conference reporter
By Gregory L. Krauss, MD

Multiple Myeloma

Frail and/or Older Patients With Multiple Myeloma: ASH 2020 Roundup

conference reporter
By S. Vincent Rajkumar, MD

Aggressive B-Cell Lymphoma

Unmet Treatment Needs in Aggressive B-Cell Lymphoma

conference reporter
By David Miklos, MD, PhD

Multiple Myeloma

Updates on Multiple Myeloma and Immunoglobulin Light Chain Amyloidosis

conference reporter
By Robert Z. Orlowski, MD, PhD

Epilepsy

Achieving Seizure Freedom in Patients With Drug-Resistant Epilepsy

conference reporter
By Gregory L. Krauss, MD

Aggressive B-Cell Lymphoma

Novel and Evolving Therapeutic Constructs in Aggressive B-Cell Lymphoma

conference reporter
By Jeremy S. Abramson, MD, MMSc

Multiple Myeloma

CAR T-Cell Therapies, Bispecific Antibodies, and Antibody Conjugates

conference reporter
By Robert Z. Orlowski, MD, PhD

Aggressive B-Cell Lymphoma

Treatment of Double-Hit Lymphomas and Other High-Risk Subsets

conference reporter
By Jeremy S. Abramson, MD, MMSc

Epilepsy

Conference Reporter in Epilepsy to Cover Key Topics Being Presented at AES2020

conference reporter
By Gregory L. Krauss, MD; John M. Stern, MD; Sara Hocker, MD, FAAN

Aggressive B-Cell Lymphoma

Conference Reporter in Aggressive B-Cell Lymphoma to Cover Key Topics Being Presented at the 62nd ASH Annual Meeting and Exposition

conference reporter
By David Miklos, MD, PhD; Frederick L. Locke, MD; Jeremy S. Abramson, MD, MMSc

Multiple Myeloma

Conference Reporter in Multiple Myeloma to Cover Key Topics Being Presented at the 62nd ASH Annual Meeting and Exposition

conference reporter
By Paul G. Richardson, MD; Robert Z. Orlowski, MD, PhD; S. Vincent Rajkumar, MD

Influenza

Allaying Parental Concerns About Chemicals in Vaccines

conference reporter
By Sean O’Leary, MD, MPH

Influenza

Visual Indications of Infections and Their Mimickers

conference reporter
By Tina Q. Tan, MD, FAAP, FIDSA, FPIDS

Influenza

The Red Book Committee: Questions and Answers

conference reporter
By Mark H. Sawyer, MD, FAAP, FIDSA; Sean O’Leary, MD, MPH

Influenza

Antimicrobial Update: Current Susceptibility Data and Trends

conference reporter
By Mark H. Sawyer, MD, FAAP, FIDSA

Influenza

Improving Vaccination Rates and Reducing Vaccine Hesitancy

conference reporter
By Mark H. Sawyer, MD, FAAP, FIDSA; Sean O’Leary, MD, MPH; Tina Q. Tan, MD, FAAP, FIDSA, FPIDS

Influenza

Changes in Vaccine Recommendations: Review and Updates

conference reporter
By Tina Q. Tan, MD, FAAP, FIDSA, FPIDS

Influenza

Conference Reporter in Influenza to Cover Key Topics Being Presented at the 2020 AAP Virtual National Conference & Exhibition

conference reporter
By Mark H. Sawyer, MD, FAAP, FIDSA; Sean O’Leary, MD, MPH; Tina Q. Tan, MD, FAAP, FIDSA, FPIDS

Multiple Myeloma

CD38 and Its Expanding Role as an Immunomodulator and Druggable Target

conference reporter
By Paul G. Richardson, MD

Multiple Myeloma

Refractory Multiple Myeloma: Tailoring Treatment to Patient Characteristics

conference reporter
By S. Vincent Rajkumar, MD

Multiple Myeloma

Novel Agents in the Approach to Patients With High-Risk Multiple Myeloma

conference reporter
By Robert Z. Orlowski, MD, PhD

Multiple Myeloma

Clinical Considerations in Initial Treatment of Newly Diagnosed Patients With Multiple Myeloma

conference reporter
By Paul G. Richardson, MD; Robert Z. Orlowski, MD, PhD; S. Vincent Rajkumar, MD

Multiple Myeloma

Treatment of Patients With Relapsed and/or Refractory and High-Risk Multiple Myeloma

conference reporter
By Paul G. Richardson, MD; Robert Z. Orlowski, MD, PhD; S. Vincent Rajkumar, MD

Multiple Myeloma

Multiple Myeloma Session Roundup: Minimal Residual Disease Assessment and Implications

conference reporter
By Paul G. Richardson, MD; Robert Z. Orlowski, MD, PhD; S. Vincent Rajkumar, MD

Multiple Myeloma

Conference Reporter in Multiple Myeloma to Cover Key Topics Being Presented at the ASCO20 Virtual Scientific Program and the Virtual Edition of the 25th EHA Annual Congress

conference reporter
By Paul G. Richardson, MD; Robert Z. Orlowski, MD, PhD; S. Vincent Rajkumar, MD

Rheumatoid Arthritis

Managing Pain in Rheumatology: Learning From the Opioid Epidemic

conference reporter
By Leonard H. Calabrese, DO

Rheumatoid Arthritis

Nonalcoholic Fatty Liver Disease in Rheumatoid Arthritis and Use of Hepatotoxic Medications

conference reporter
By Leonard H. Calabrese, DO

Rheumatoid Arthritis

Patient Management Principles for Difficult-to-Treat Rheumatoid Arthritis

conference reporter
By Alan L. Epstein, MD

Rheumatoid Arthritis

Pregnancy in Rheumatoid Arthritis: Principles for Clinical Practice

conference reporter
By Jonathan Kay, MD

Rheumatoid Arthritis

Cardiovascular Comorbidity in Rheumatoid Arthritis

conference reporter
By Alan L. Epstein, MD

Rheumatoid Arthritis

Vaccination Strategies for Patients With Rheumatoid Arthritis

conference reporter
By Jonathan Kay, MD

Rheumatoid Arthritis

Conference Reporter in Rheumatoid Arthritis to Cover Key Topics at 2019 ACR/ARP Annual Meeting

conference reporter
By Alan L. Epstein, MD; Jonathan Kay, MD; Leonard H. Calabrese, DO